Subscribe to RSS
DOI: 10.1055/s-0028-1112133
© Georg Thieme Verlag KG Stuttgart · New York
Effects of Quetiapine on Cognitive Functions in Schizophrenic Patients: A Preliminary Single-trial ERP Analysis
Publication History
received 24.07.2008
revised 12.11.2008
accepted 13.11.2008
Publication Date:
07 July 2009 (online)

Abstract
Aim: The study aimed to explore by means of single-trial event-related potentials (ERPs), whether and how the medication change from older neuroleptics to quetiapine in schizophrenic patients led to a significant cognitive enhancement. This single-trial ERP analysis helps to investigate attention and memory processes in the single patient before and after treatment.
Patients and Methods: Thirteen schizophrenic patients (mean age: 40.1±13.5 years) were followed up for 16 weeks and assessed for changes of clinical symptoms and ERP components P300 representing target detection processes and N400 indexing context integration in word recognition processes. Three subjects had to be excluded from the ERP recording sessions because of excessive blink artefacts and movements.
Results: Regarding the P300 components of the target detection, there were significant increases of amplitudes in 5 of 10 patients (50%) at week 16 comparing with week 0. Regarding the N400 components of the word recognition, there were significant increases of amplitudes in 4 of 10 patients (40%) at week 16 comparing with week 0.
Discussion: The mean scores of PANSS, MADRS, Bf-S, SCL-90 and CGI-S at the end of study (week 16) showed significant improvements compared to the baselines (week 0) (p<0.05). During the study, no extrapyramidal symptoms as well as akathisia were reported after quetiapine treatment. These preliminary data suggest that quetiapine might partially improve the cognitive functions in the context integration and target detection processing in these patients. This technical procedure (single-trial ERP) may help to differentially assess cognitive enhancements in each single patient under treatment.
References
-
1
American Psychiatric Association
.
Diagnostic and statistical manual of mental disorders, 4th edn, (DSM-IV) . Washington, DC: American Psychiatric Association 1994 -
2 Basar E. Wavelet analysis of brain waves. In:
Brain Function and Oscillations, Part I: Brain Oscillations: Principles and Approaches . Berlin: Springer-Verlag 1998: 107-121 - 3 Bramon E, Rabe-Hesketh S, Sham P. et al . Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res. 2004; 70 315-329
- 4 Dietrich DE, Emrich HM, Waller C. et al . Emotion/cognition-coupling in word recognition memory of depressive patients: an event-related potential study. Psychiatry Res. 2000; 96 15-29
- 5 Dietrich DE, Hauser U, Peters M. et al . S100B blood levels and target evaluation processes in remitted patients with recurrent major depression. Neurosci Lett. 2004; 354 69-73
- 6 Dietrich DE, Kleinschmidt A, Hauser U. et al . Word recognition memory before and after successful treatment of depression. Pharmacopsychiatry. 2000; 33 221-228
- 7 Göder R, Fritzer G, Gottwald B. et al . Effects of olanzapine on slow wave sleep, sleep spindles and sleep-related memory consolidation in schizophrenia. Pharmacopsychiatry. 2008; 41 92-99
-
8 Hillyard SA, Mangun GR, Woldorff MG. et al .Neural System Mediating Selective Attention. In: Gazzaniga MS, ed.
The Cognitive Neurosciences . Cambridge: MIT Press 1995: 665-682 -
9 Hillyard SA, Picton TW. Electrophysiology of cognition. In: Plum F, ed.
Handbook of Physiology, Section 1: Neurophysiology . New York: American Physiological Society 1987: 519-584 - 10 Iwanami A, Okajima Y, Isono H. et al . Effects of risperidone on event-related potentials in schizophrenic patients. Pharmacopsychiatry. 2001; 34 73-79
- 11 Jann MW. Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesis. Pharmacotherapy. 2004; 24 1759-1783
- 12 Johannes S, Wieringa BM, Manthey M. et al . Altered inhibition of motor responses in Tourette syndrome and obsessive-compulsive disorder. Acta Neurol Scand. 2001; 104 36-43
-
13 Johnson R. Event-related potential insights into the neurobiology of memory systems. In: Boller F, Grafman J, eds.,
Handbook of neuropsychology . Amsterdam: Elsevier 1995 10: 135-163 - 14 Jones HM, Brammer MJ, O’Toole M. et al . Cortical effects of quetiapine in first-episode schizophrenia: a preliminary functional magnetic resonance imaging study. Biol Psychiatry. 2004; 56 938-942
-
15 Luck SJ.
An Introduction to the Event-Related Potential Technique . London: MIT Press 2005 - 16 Meltzer HY, MacGurk SR. The effects of clozapine, risperidone, and quetiapine on cognitive function in schizophrenia. Schizophrenia Bull. 1999; 25 233-255
- 17 Molina V, Muñoz F, Martín-Loeches M. et al . Long-term olanzapine treatment and p300 parameters in schizophrenia. Neuropsychobiology. 2004; 50 182-188
- 18 Molina V, Reig S, Sanz J. et al . Changes in cortical volume with olanzapine in chronic schizophrenia. Pharmacopsychiatry.. 2007; 40 135-139
- 19 Purdon SE, Jones BD, Stip E. et al . Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Group for research in schizophrenia. Arch Gen Psychiatry. 2000; 57 249-258
- 20 Purdon SE, Malla A, Labelle A. et al . Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci. 2001; 26 137-149
-
21 Rugg MD. Event-Related Potential Studies of Human Memory. In: Gazzaniga MS, ed.
The Cognitive Neurosciences . Cambridge: Bradford Book 1995: 789-801 - 22 Velligan DI, Prihoda TJ, Sui D. et al . The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings. J Clin Psychiatry. 2003; 64 524-531
- 23 Woodward ND, Purdon SE, Meltzer HY. et al . A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol. 2005; 8 457-472
- 24 Zhang Y, Ennen J, Lehmann M. et al . Memory and attention processes in schizophrenic patients treated with olanzapine: a single-trial ERP analysis. Der Nervenarzt. 2006; ((Suppl. 3)) 156
Correspondence
Dr. Y. Zhang
Clinic for Psychiatry, Social Psychiatry and Psychotherapy
OE 7110
Medical School Hanover
Carl-Neuberg-Str. 1
30625 Hanover
Germany
Phone: +49/511/532 67 58
Fax: +49/511/532 24 15
Email: Zhang.yuanyuan@mh-hannover.de